The frequency of TNFRSF13B gene mutations was significantly higher in CVID compared to healthy controls (p < 0.0001), with the exception of monoallelic C104R mutations (p = ns) (Table 1(a)). This evidence concerns the gene TNFRSF13B and common variable immunodeficiency.